comparemela.com

Latest Breaking News On - David larsen - Page 23 : comparemela.com

BTIG Remains a Buy on Evolent Health (EVH)

BTIG analyst David Larsen maintained a Buy rating on Evolent Health (EVH – Research Report) today and set a price target of $45.00. The co.

Sharecare, Inc (NASDAQ:SHCR) Q4 2022 Earnings Call Transcript

A Valuable Early-warning System for Disease Outbreaks Could Be Shut Down

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.